[CLINICAL TESTING OF OXYLIDIN, A NEW HYPOTENSIVE AGENT, IN THE TREATMENT OF HYPERTENSION].
D000959:Antihypertensive Agents; D035843:Biomedical Research; D004358:Drug Therapy; D005730:Ganglionic Blockers; D006801:Humans; D006973:Hypertension; D006993:Hypnotics and Sedatives; D011812:Quinuclidines; D013565:Sympatholytics
D000959:Antihypertensive Agents; D005730:Ganglionic Blockers; D006993:Hypnotics and Sedatives; D011812:Quinuclidines; D013565:Sympatholytics; C000662:benzoclidine
ANTIHYPERTENSIVE AGENTS; CLINICAL RESEARCH; DRUG THERAPY; GANGLIONIC BLOCKADERS; HYPERTENSION; HYPNOTICS AND SEDATIVES; SYMPATHOLYTICS
KLINICHESKOE ISPYTANIE NOVOGO GIPOTENZVNOGO SREDSTVA-OKSILIDINA-PRI LECHENII BOL'NYKH GIPERTONICHESKOI BOLEZN'IU.